Cairo University
Cairo, 11553, Egypt
NCT Number: NCT03335007
The aim of this prospective, randomized, double-blind, clinical trial is to evaluate the effect of a preoperative, single, oral dose of aceclofenac (100 mg) on postendodontic pain at 6, 24 and 48 hours, postoperative pain at injection area at 6, 24 and 48 hours and analgesic intake after single-visit root canal treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2 / Phase 3
Cairo, 11553, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aceclofenac 100 mg tablet given one hour before starting the root canal treatment
Other names: Bristaflam
Placebo tablet given one hour before starting the root canal treatment
Time frame: At 6, 24 and 48 hours after root canal treatment.
Postendodontic pain will be measured using Heft-Parker visual analogue scale. No or mild pain response will be considered success.
Time frame: At 6, 24 and 48 hours after root canal treatment.
Postoperative pain at injection area will be measured with Heft-Parker visual analogue scale. No or mild pain response will be considered success.
Time frame: Within 48 hours after single root canal treatment.
Incidence of analgesic intake
Cairo University
Other
Pretreatment Aceclofenac Effect on Pain and Analgesic Intake After Endodontic Treatment: A Randomized, Double-blind, Placebo-controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07332936
Neurologic Manifestations, Pain
Mecca, Saudi Arabia
View Trial DetailsNCT05600023
Neurologic Manifestations, Pain
Karachi, Sindh, Pakistan
View Trial DetailsNCT05306470
Neurologic Manifestations, Pain
Karachi, Sindh, Pakistan
View Trial DetailsNCT07290049
Neurologic Manifestations, Pain
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial Details